HKEX: 2169
(1) Connected transaction in relation to subscription of shares under specific mandate and (2) application for whitewash waiver
View original source (HKEXnews)
Earlier from Canggang Railway
- Interim Report 2026
- Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease